01 1HENANA LIHUA PHARMACEUTICALS CO., INC.
01 1DEXAMETHASONE PALMITATE
01 1Blank
NDC Package Code : 64958-0108
Start Marketing Date : 2025-08-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
81
PharmaCompass offers a list of Dexamethasone Palmitate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dexamethasone Palmitate manufacturer or Dexamethasone Palmitate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dexamethasone Palmitate manufacturer or Dexamethasone Palmitate supplier.
A Dexamethasone Palmitate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexamethasone Palmitate, including repackagers and relabelers. The FDA regulates Dexamethasone Palmitate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexamethasone Palmitate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dexamethasone Palmitate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Dexamethasone Palmitate supplier is an individual or a company that provides Dexamethasone Palmitate active pharmaceutical ingredient (API) or Dexamethasone Palmitate finished formulations upon request. The Dexamethasone Palmitate suppliers may include Dexamethasone Palmitate API manufacturers, exporters, distributors and traders.
click here to find a list of Dexamethasone Palmitate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dexamethasone Palmitate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dexamethasone Palmitate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dexamethasone Palmitate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dexamethasone Palmitate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dexamethasone Palmitate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dexamethasone Palmitate suppliers with NDC on PharmaCompass.
